NanoViricides Engages CRO for Phase II Clinical Trial
SHELTON, CT / ACCESS Newswire / January 27, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that it has ...
healthcareasia5d
Advancing ASEAN Public Health Through Effective Regional Disease Management, Partnerships
Southeast Asia continues to face pressing health challenges, with diseases such as tuberculosis and malaria remaining prevalent in several nations. In response, regional governments and organizations ...